Patents by Inventor Robert S. Meidell

Robert S. Meidell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6503498
    Abstract: The present disclosure demonstrates the successful use of adenovirus mediated gene transfer to increase HDLc in mammalian cells and in mice. BALB/c mice were infected with recombinant adenovirus containing a gene encoding human apolipoprotein A-I (AdCMVApo-I). Immunoreactive apoA-I averaged 168 mg/dl 5 days after infection. HDLc was increased by 35% in infected mice. Lipoprotein analysis revealed that human apoA-I is incorporated into murine HDL particles, producing transient elevations of circulating HDLc of a magnitude correlated with important physiologic effects. Also disclosed are pharmacological preparations to be used to increase serum HDLc in a subject.
    Type: Grant
    Filed: April 5, 1994
    Date of Patent: January 7, 2003
    Assignee: Board of Regents, The University of Texas System
    Inventors: Robert D. Gerard, Robert S. Meidell, John E. Willard